-
1 Comment
Brainsway Ltd is currently in a long term uptrend where the price is trading 18.5% above its 200 day moving average.
From a valuation standpoint, the stock is 99.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.8.
Brainsway Ltd's total revenue rose by 12.3% to $7M since the same quarter in the previous year.
Its net income has increased by 82.5% to $-406K since the same quarter in the previous year.
Finally, its free cash flow grew by 28.9% to $-1M since the same quarter in the previous year.
Based on the above factors, Brainsway Ltd gets an overall score of 5/5.
Exchange | NASDAQ |
---|---|
CurrencyCode | USD |
Sector | Healthcare |
Industry | Medical Devices |
ISIN | US10501L1061 |
Market Cap | 174M |
---|---|
PE Ratio | 51.17 |
Target Price | 14.55 |
Beta | 0.16 |
Dividend Yield | None |
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, East Asia, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for BWAY using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025